Skip to content
naulon
Not checkedNot checked for notices yet.

Síndrome de infusión por propofol en el adulto

Aranda Fernando, Caracci Bruno

Revista Chilena de Anestesia · 2019

doi:10.25237/revchilanestv47n03.05 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Propofol infusion syndrome is a rare but lethal complication of propofol administration.The most common clinical presentation is high anion-gap metabolic acidosis, heart failure, rhabdomyolysis and hyperkalemia in patients receiving a prolonged propofol infusion.It has an estimated incidence of 1,1% in patients receiving propofol and its mortality varies between 18 and 81%.The most important risk factor is an infusion over 4 mg/kg/h of propofol and a critically sick patient.Management of a diagnosed PRIS is based on immediate discontinuation of propofol and support therapy.resumen El síndrome de infusión de propofol es una complicación rara, pero posiblemente letal de la administración de propofol (Propofol Infusion Syndrome, PRIS) Generalmente, se presenta como una acidosis metabólica con anion Gap aumentado, falla cardiaca rápidamente progresiva, rabdomiólisis e hiperkalemia, junto con el antecedente claro de una infusión prolongada de la droga.La incidencia se estima en un 1,1% en los pacientes que reciben propofol y su mortalidad varía entre el 18 al 81%.Los factores de riesgo son: una infusión de propofol mayor a 4 mg/kg/h y pacientes críticos.El tratamiento se basa en la suspensión de la droga y medidas de soporte hemodinámico.

Abstract licence: CC BY-NC

References18

  1. 1.

17 more references, whose wording the paper’s licence keeps private.

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.